Life-threatening lung cancer has taught me many valuable lessons and made my new normal so fulfilling. My life has changed ...

Dr. Moghanaki joins a prestigious board of lung cancer experts committed to attracting top researchers to the field of lung ...

At only age 28, the newlywed and busy teacher initially dismissed her symptoms. As her cough and fatigue worsened, she ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

A woman has revealed her shock at being diagnosed with cancer and cured of it within the same day. April Boudreau, from Texas ...

Sarcopenia influences toxicity and survival in non-small cell lung cancer, and sarcopenia assessment can be factored into ...

IMFINZITM (durvalumab) has received approval in the European Union as a monotherapy for treating adults with limited-stage ...

Data evaluating safety and injection feasibility from a Phase 1 study of JNJ-1900 (NBTXR3) in combination nivolumab or ...

The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) as monotherapy for the treatment of adults with limited-stage small cell lung cancer (LS-SCLC) whose disease has not ...